WorldQuant Millennium Advisors’s West Pharmaceutical WST Stock Holding History

WorldQuant Millennium Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.2M	Buy	268,107 +253,914	+1,789%	+$63.2M	0.26%	102
2025 Q4	$3.91M	Sell	14,193 -169,477	-92%	-$46.4M	0.02%	353
2025 Q3	$48.2M	Sell	183,670 -129,651	-41%	-$31.5M	0.21%	130
2025 Q2	$68.6M	Buy	313,321 +45,050	+17%	+$9.63M	0.34%	76
2025 Q1	$60.1M	Buy	+268,271	New	+$73.9M	0.38%	81
2024 Q2	–	Sell	-3,261	Closed	-$1.29M	–	478
2024 Q1	$1.29M	Buy	+3,261	New	+$1.21M	0.02%	303
2023 Q1	–	Sell	-23,366	Closed	-$5.5M	–	416
2022 Q4	$5.5M	Sell	23,366 -15,497	-40%	-$3.67M	0.13%	201
2022 Q3	$9.56M	Buy	+38,863	New	+$11.8M	0.23%	132
2022 Q1	–	Sell	-3,707	Closed	-$1.74M	–	371
2021 Q4	$1.74M	Buy	+3,707	New	+$1.6M	0.03%	267

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WorldQuant Millennium Advisors's WST Position: Q1 2026 in Review

WorldQuant Millennium Advisors increased its West Pharmaceutical (WST) stake by 1,789% in Q1 2026, buying an estimated $63.2M and bringing the position to 268,107 shares worth $67.2M. The position accounts for 0.26% of the portfolio, ranked #102.

WorldQuant Millennium Advisors first reported a position in WST in Q4 2021 and has held it in 9 quarters since. The position peaked at $68.6M in Q2 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

WorldQuant Millennium Advisors held 268,107 shares of West Pharmaceutical worth $67.2M as of Q1 2026.
WorldQuant Millennium Advisors bought 253,914 West Pharmaceutical shares in Q1 2026, an estimated $63.2M.
West Pharmaceutical made up 0.26% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #102 holding.
WorldQuant Millennium Advisors first reported a position in West Pharmaceutical in Q4 2021 and has held it in 9 quarters since.
WorldQuant Millennium Advisors's West Pharmaceutical position peaked at $68.6M in Q2 2025.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.